Pfizer : PFE

All Pfizer Articles

1465 Articles

Chris Lange | Aug 28, 2015 at 9:35 AM EDT

Meet the Newest Additions to the S&P 500

The S&P 500 is adding two new components: Activision Blizzard and United Continental.

Lee Jackson | Aug 27, 2015 at 9:15 AM EDT

Deutsche Bank Says Stick With Top Stocks Growing Dividends

If investors have dry powder or have raised cash by selling higher beta momentum stocks, these stocks may make good…

Chris Lange | Aug 26, 2015 at 8:05 AM EDT

Short Sellers Have Mixed Feelings on Major Pharma

The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Jon C. Ogg | Aug 24, 2015 at 2:09 PM EDT

Pfizer Gets Approval For Hospira Acquisition

ThinkstockAt a time when there is pressure on how large US companies are making domestic or overseas acquisitions are coming…

Lee Jackson | Aug 24, 2015 at 10:50 AM EDT

4 Event-Driven Stocks to Buy for the Rest of 2015

A new research note from Jefferies lists stocks that could have meaningful events soon. The stocks in some cases have…

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2015 at 12:25 PM EDT

5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction

24/7 Wall St. maintains on its watch list a slew of defensive dividend stocks that investors flock to during periods…

Paul Ausick | Aug 6, 2015 at 4:01 PM EDT

The 4 Stocks That Dragged Down the DJIA on Thursday

thinkstockAugust 6, 2015: Markets opened higher again on Thursday but not by much and equities quickly turned south and remained…

Lee Jackson | Aug 6, 2015 at 8:35 AM EDT

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term…

Lee Jackson | Jul 31, 2015 at 10:05 AM EDT

4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015

ThinkstockFor the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well…

Jon C. Ogg | Jul 29, 2015 at 8:54 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet…

Paul Ausick | Jul 28, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Tuesday

thinkstockJuly 28, 2015: Markets opened higher on Tuesday after the Shanghai market closed with a modest loss compared with Monday’s…

Paul Ausick | Jul 28, 2015 at 7:42 AM EDT

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

ThinkstockPfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted…

Paul Ausick | Jul 27, 2015 at 2:17 PM EDT

What to Look For in Pfizer Earnings

Wikimedia CommonsBefore the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

1 … 56 57 58 59 60 … 98

Pfizer : PFE

All Pfizer Articles

Meet the Newest Additions to the S&P 500

Deutsche Bank Says Stick With Top Stocks Growing Dividends

Short Sellers Have Mixed Feelings on Major Pharma

Pfizer Gets Approval For Hospira Acquisition

4 Event-Driven Stocks to Buy for the Rest of 2015

Short Sellers Back Off Big Pharma

5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction

The 4 Stocks That Dragged Down the DJIA on Thursday

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

The 4 Stocks That Lifted the Dow on Tuesday

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

What to Look For in Pfizer Earnings

Short Sellers Run For Cover From Major Pharma

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Pfizer : PFE

All Pfizer Articles

Meet the Newest Additions to the S&P 500

Deutsche Bank Says Stick With Top Stocks Growing Dividends

Short Sellers Have Mixed Feelings on Major Pharma

Pfizer Gets Approval For Hospira Acquisition

4 Event-Driven Stocks to Buy for the Rest of 2015

Short Sellers Back Off Big Pharma

5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction

The 4 Stocks That Dragged Down the DJIA on Thursday

4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends

4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

The 4 Stocks That Lifted the Dow on Tuesday

Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs

What to Look For in Pfizer Earnings

Short Sellers Run For Cover From Major Pharma

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts